ventavis
Ventavis (Iloprost) is a prostacycline used to treat Pulmonary Hypertension.
Iloprost · by Actelion
Key facts
- Active ingredient
- Iloprost
- Drug class
- Prostacycline
- Form
- Solution
- Strength
- Iloprost 10MCG/ML (10MCG/ML) **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Iloprost 20MCG/2ML (10MCG/ML) **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Iloprost 20MCG/ML (20MCG/ML) **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- pulmonary hypertension
- Manufacturer
- Actelion
- FDA application
- NDA021779
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Solution
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Ventavis treat?
- Ventavis (Iloprost) may be used to treat pulmonary hypertension, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Ventavis?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Ventavis. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Ventavis?
- Ventavis is marketed by Actelion. You can see Actelion's full profile, rating, and other products on pharmaranks.
- Is Ventavis a brand-name or generic drug?
- Ventavis is a brand-name product with the active ingredient Iloprost.
- Is Ventavis available over the counter?
- No. Ventavis is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Ventavis come in?
- Ventavis is currently marketed as solution, per the FDA's National Drug Code Directory.
- What class of drug is Ventavis?
- Ventavis is classified as prostacycline, per the FDA's Established Pharmacologic Class.
- Is Ventavis FDA-registered?
- Ventavis is on record with the U.S. FDA under application number NDA021779. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ILOPROST
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,317 reports naming ILOPROST — the active ingredient in Ventavis, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- dyspnoea106 reports
- right ventricular failure83 reports
- pulmonary arterial hypertension63 reports
- headache57 reports
- hypotension55 reports
- pulmonary hypertension53 reports
- nausea47 reports
- pneumonia45 reports
Read these as a signal, not a rate. A report does not mean ILOPROST caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Ventavis head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
ventavis
New